New integration demonstrates how potential consumer applications can be developed on Mojo Lens SARATOGA, Calif.–(BUSINESS WIRE)–Mojo Vision, the Invisible Computing Company, announced today that it had developed a potential consumer implementation of Alexa Shopping List on its Mojo Lens prototype. It was the first major third-party consumer application on a smart contact lens. The test … [Read more…]
CAMBRIDGE, England–(BUSINESS WIRE)–#CBT—ieso, a healthcare company pioneering digital therapeutics in mental health that improve patient access and outcomes, announced today that the UK Department of International Trade (DIT) has selected the company as one of the delegates to exhibit on the UK pavilion at HLTH 2022, a leading health innovation summit, held November 13-16 at … [Read more…]
Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industry CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, today announced it has been named “Overall BioTech Company of the Year” in the second annual BioTech Breakthrough Awards program conducted by BioTech Breakthrough, … [Read more…]
TORONTO–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, is pleased to announce its participation in the following upcoming investor events: Jefferies London Healthcare Conference, November 15-17, 2022 Doug Drysdale, Cybin’s Chief Executive Officer, will present on November 15, 2022 at 8:00 a.m. GMT and … [Read more…]
The Wisconsin Department of Health Services awards Pear funding towards access to Pear’s reSET® and reSET-O® to patients with substance use disorder and opioid use disorder The program will support Wisconsinites on their recovery journeys with innovative FDA-authorized treatments via their mobile devices, aligned with DHS’ focus on supporting individual and community health and well-being … [Read more…]
– LINZESS® (Iinaclotide) EUTRx prescription demand growth in Q3 2022 increased 10% year-over-year – – Ironwood and its partner, AbbVie, plan to submit a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a potential indication in functional constipation in pediatric patients aged 6-17 by the end of 2022 – … [Read more…]
BOSTON–(BUSINESS WIRE)–Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the third quarter 2022 financial results and provide a corporate update on Thursday, November 10, 2022, at 4:30 p.m. Eastern/1:30 p.m. Pacific. Conference Call and Webcast: Thursday, November 10, … [Read more…]
Key financial highlights and outlook Revenues of $3.6 billion GAAP diluted EPS of $0.05 Non-GAAP diluted EPS of $0.59 Cash flow generated from operating activities of $543 million Free cash flow of $685 million 2022 revenues outlook revised mainly due to continued foreign exchange headwinds; non-GAAP tax rate outlook range revised to 12% – 14%; … [Read more…]
– Continued clinical progress across pipeline including BT5528 end of Phase I dose escalation update; completion of enrollment in BT5528 initial dose expansion cohorts expected in Q4 – BT8009 clinical update remains on-track for Q4 – Received $10 million option fee payment from Genentech this quarter triggered by exclusive strategic collaboration expansion option exercise in … [Read more…]
Third quarter 2022 core Lung Diagnostic revenue of $9.2 million increased 102% over the comparable period in 2021; U.S. Federal Supply Schedule Contract expands coverage to Veterans Health Administration and Military Health System Medical Centers for its entire Lung Diagnostic portfolio; Conference Call and Webcast Today at 8:00 a.m. ET BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. … [Read more…]
